Please Wait
Applying Filters...
menu
    • menu
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Evonik

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Benzyl Alcohol

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1ADREVIEW

    02 6MESNA

    03 1THALLOUS CHLORIDE TL 201

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers

    01

    GE HEALTHCARE

    IOBENGUANE SULFATE I-123

    arrow
    RDD 2025
    Not Confirmed
    GE HEALTHCARE
    United Kingdom
    arrow
    RDD 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    IOBENGUANE SULFATE I-123

    Drug : ADREVIEW

    Dosage Form : SOLUTION; INTRAVENOUS

    Application Number : 22290

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    GLAND

    MESNA

    arrow
    RDD 2025
    Not Confirmed
    GLAND
    India
    arrow
    RDD 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MESNA

    Drug : MESNA

    Dosage Form : INJECTABLE; INTRAVENOUS

    Application Number : 206992

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    HIKMA

    MESNA

    arrow
    RDD 2025
    Not Confirmed
    HIKMA
    United Kingdom
    arrow
    RDD 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MESNA

    Drug : MESNA

    Dosage Form : INJECTABLE; INTRAVENOUS

    Application Number : 75739

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    LANTHEUS MEDCL

    THALLOUS CHLORIDE TL-201

    arrow
    RDD 2025
    Not Confirmed
    LANTHEUS MEDCL
    U.S.A
    arrow
    RDD 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    THALLOUS CHLORIDE TL-201

    Drug : THALLOUS CHLORIDE TL 201

    Dosage Form : INJECTABLE; INTRAVENOUS

    Application Number : 17806

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    RISING

    MESNA

    arrow
    RDD 2025
    Not Confirmed
    RISING
    U.S.A
    arrow
    RDD 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MESNA

    Drug : MESNA

    Dosage Form : INJECTABLE; INTRAVENOUS

    Application Number : 203364

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    SAGENT PHARMS INC

    MESNA

    arrow
    RDD 2025
    Not Confirmed
    SAGENT PHARMS INC
    U.S.A
    arrow
    RDD 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MESNA

    Drug : MESNA

    Dosage Form : INJECTABLE; INTRAVENOUS

    Application Number : 90913

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    TEVA PHARMS USA

    MESNA

    arrow
    RDD 2025
    Not Confirmed
    TEVA PHARMS USA
    Israel
    arrow
    RDD 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MESNA

    Drug : MESNA

    Dosage Form : INJECTABLE; INTRAVENOUS

    Application Number : 75764

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    MYLAN INSTITUTIONAL

    MESNA

    arrow
    RDD 2025
    Not Confirmed
    MYLAN INSTITUTIONAL
    U.S.A
    arrow
    RDD 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MESNA

    Drug : MESNA

    Dosage Form : INJECTABLE; INTRAVENOUS

    Application Number : 76488

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF